RNS Number : 2879R
Legal & General UCITS ETF PLC
26 June 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
26/06/2020 |
IE00BFXR5Q31 |
11767267 |
USD |
133184342.86 |
11.318 |
| L&G UK Equity UCITS ETF |
26/06/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
10937435.48 |
9.115 |
| L&G Global Equity UCITS ETF |
26/06/2020 |
IE00BFXR5S54 |
2900000 |
USD |
31893463.90 |
10.998 |
| L&G Japan Equity UCITS ETF |
26/06/2020 |
IE00BFXR5T61 |
11085000 |
USD |
117277862.30 |
10.580 |
| L&G Europe ex UK Equity UCITS ETF |
26/06/2020 |
IE00BFXR5V83 |
9360988 |
EUR |
99220729.52 |
10.599 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
26/06/2020 |
IE00BFXR5W90 |
4605639 |
USD |
47337153.86 |
10.278 |
| L&G Clean Water UCITS ETF |
26/06/2020 |
IE00BK5BC891 |
1500000 |
USD |
15025367.53 |
10.017 |
| L&G Artificial Intelligence UCITS ETF |
26/06/2020 |
IE00BK5BCD43 |
6496000 |
USD |
81229053.20 |
12.504 |
| L&G Healthcare Innovation UCITS ETF |
26/06/2020 |
IE00BK5BC677 |
2650000 |
USD |
32302162.36 |
12.189 |
| L&G Pharma Breakthrough UCITS ETF |
26/06/2020 |
IE00BF0H7608 |
2500000 |
USD |
29808842.43 |
11.924 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
26/06/2020 |
IE00BKLTRN76 |
9200000 |
EUR |
92311464.04 |
10.034 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
26/06/2020 |
IE00BKLWY790 |
57300000 |
USD |
583924678.37 |
10.191 |
| L&G Battery Value-Chain UCITS ETF |
26/06/2020 |
IE00BF0M2Z96 |
12050000 |
USD |
108641470.63 |
9.016 |
| L&G Ecommerce Logistics UCITS ETF |
26/06/2020 |
IE00BF0M6N54 |
5500000 |
USD |
57535687.06 |
10.461 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
26/06/2020 |
IE00BMW3QX54 |
47730616 |
USD |
804134501.65 |
16.847 |
| L&G Cyber Security UCITS ETF |
26/06/2020 |
IE00BYPLS672 |
81536776 |
USD |
1521203154.03 |
18.657 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVDZGZVZVMGGZZ
